OBJECTIVE: To investigate the development of enrofloxacin resistance among Escherichia coli isolates obtained from chickens by determining mutant-prevention concentrations (MPCs) and sequence the quinolone resistance-determining regions (QRDRs) of gyrA and parC genes in selected isolates. SAMPLE POPULATION: 15 chicken-derived E coli isolates. PROCEDURES: For all isolates, MPC and minimal inhibition concentration (MIC) of enrofloxacin were determined. The MPCs and maximum serum drug concentrations attained with enrofloxacin doses recommended for treatment of E coli infections in chickens were compared. Mutation frequencies and QRDR sequence changes in gyrA and parC were also determined. RESULTS: In 2 of 15 E coli strains, MPCs were low (0.016 and 0.062 microg/mL), MPC:MIC ratios were 2 and 4, and the GyrA and ParC proteins had no mutations. In 9 susceptible isolates with a GyrA point mutation, MPCs ranged from 2 to 16 microg/mL. For isolates with double mutations in GyrA and a single mutation in ParC, MPCs were > 32 microg/mL (several fold greater than the maximal plasma concentration of enrofloxacin in chickens); mutation frequencies were also much lower, compared with frequencies for single-mutation isolates. CONCLUSIONS AND CLINICAL RELEVANCE: For E coli infections of chickens, MPC appears to be useful for determining enrofloxacin-dosing strategies. The high MPC:MIC ratio may result in enrofloxacin-treatment failure in chickens infected with some wild-type gyrA E coli isolates despite the isolates' enrofloxacin susceptibility (MICs 0.125 to 1 microg/mL). For infections involving isolates with high MPCs, especially those containing mutations in gyrA and parC genes, treatment with combinations of antimicrobials should be adopted. 相似文献
This study was conducted to evaluate the use of ramie as forage on growth performance, serum biochemical indices, and meat quality of Boer goats. For this, 60 Boer lambs were divided into four groups fed the TMR with 0%, 10%, 20%, and 40% (control, and groups I, II, III, respectively) ramie. The experiment lasted for 90 days with a pretest for 15 days. Venous blood and longissimus dorsi (LD) muscle samples were collected after 24 h fasted at the end of the experiment. The results showed that ramie seems no significant changes in average daily gain (ADG) and other parameters for growth performance, only 40% ramie in TMR significantly reduced average daily feed intake (ADFI) (P < 0.05). Compared to the control, group II (20%) showed significant increases in total protein (TP) and globulin (GLB) levels, and decreases in albumin/globulin level (P < 0.05) in serum. Meanwhile, serum total cholesterol (TC) (P < 0.05) and free thyroxine (FT4) level were significantly reduced with up to 20% or more ramie in TMR. Moreover, the total amino acid and flavor amino acid levels in LD muscle were not affected by ramie. However, significant increases (P < 0.05) were observed in linoleic acid, polyunsaturated fatty acid, and polyunsaturated fatty acid/saturated fatty acid levels in group II. Overall, these results indicated that up to 20% ramie in TMR have no impairment in growth performance, health and meat quality, whereas high level ramie might have a negative effect on feed intake.
